ABLS Fact Sheet: Abacus FCF Small Cap Leaders ETF
Share
$22.07
close, Nov 18, 2026
Over the year to Nov 18, 2026, ABLS returned +11.5% in total and charged 0.39% a year.
- 1-year total return
- +11.5%
- IWM +16.9% to Nov 18, 2026
- Expense ratio
- 0.39%
- a year
- Net flow, 12 months to Jul 31, 2026
- −$698k
- monthly N-PORT basis to Jul 31, 2026
Growth of $10,000, 1 year
ABLS $11,153 +11.5% · IWM $11,687 +16.9% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+4.2%
3 months−4.7%
Year to date+10.9%
1 year+11.5%
Since launch+1.3%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Argan Inc11.79%
Enova International Inc6.46%
Oscar Health Inc5.83%
Artisan Partners Asset Managem4.38%
Collegium Pharmaceutical Inc4.27%
Healthcare Services Group Inc3.73%
Harmony Biosciences Holdings I3.58%
Qualys Inc3.40%
Kontoor Brands Inc3.39%
Progyny Inc3.32%
ABLS top ten by weight, 50.1% of the fund, of its 46 equity positions, from the holdings filed for Jul 31, 2026.
Facts
Equity fund · First traded Feb 19, 2025 · Benchmark Russell 2000 Total Return Index, measured by IWM, which tracks the same index